The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August 4, 2020 In early July, Novavax received $1.6 billion in funding as part of the federal government’s Operation Warp Speed, an initiative aiming to accelerate … Continue reading Novavax’s COVID-19 Vaccine Generates Positive Results in Phase 1 Trial